PubMed · 2018 · 27 citations · 33 references
Life SciencesMolecular BiologyOncologyApoptosisGene ExpressionMolecular OncologyApoptosis In CancerMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerRna InterferenceTumor Suppressor GenesCancer Cell ApoptosisG2 Phase ProgressionG2 Phase RegulationMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerPost-transcriptional Gene RegulationPost-transcriptional Regulation
. In addition, as a critical target of miR-520d-3p, the activity of spindle and kinetochore associated 2 (SKA2) was greatly inhibited by miR-520d-3p, and overexpression of miR-520d-3p decreased the expression of SKA2. SKA2 downregulation suppressed cell viability, whereas restoration of SKA2 expression significantly reversed the inhibitory effects of miR-520d-3p antitumor activity. Furthermore, SKA2 was frequently overexpressed in clinical specimens and cell lines, and the expression levels were statistically inversely correlated with miR-520d-3p expression. In conclusion, our data demonstrated that miR-520d-3p antitumor activity is achieved by targeting the SKA2 in human breast cancer cells, suggesting that miR-520d-3p may be a potential target molecule for the therapy.
33
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
miR-206 Expression Is Down-regulated in Estrogen Receptor α–Positive Human Breast Cancer
Naoto Kondo, Tatsuya Toyama, Hiroshi Sugiura et al. · Cancer Research · 2008 · 302 citations · Full text
MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
Wei Shi, Kate Gerster, Nehad M. Alajez et al. · Cancer Research · 2011 · 266 citations · Full text
miR‐301a as an NF‐κB activator in pancreatic cancer cells
Zhongxin Lu, Yan Li, Yong Li et al. · The EMBO Journal · 2010 · 226 citations · Full text
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Masato Nishimura, Eun‐Jung Jung, Maitri Shah et al. · Cancer Discovery · 2013 · 161 citations · Full text
Medicine, Oncology, Pharmacology +17